Bidens pilosa Formulation Improves Blood Homeostasis and β-Cell Function in Men: A Pilot Study

Table 2

Selected biochemical parameters of healthy volunteers after administration with the B. pilosa formulation for 3 months.

Parameters^a

HbA1c (%)

FBG (mg/dL)

PBG (mg/dL)

Fasting insulin (mU/L)

Postprandial insulin (mU/L)

TRIG (mg/dL)

TC (mg/dL)

HDL-c (mg/dL)

LDL-c (mg/dL)

AST (U/L)

ALT (U/L)

BUN (mg/dL)

Creatinine (mg/dL)

Pretreatment; ()

5.4 ± 0.3

87.6 ± 2.3

111.6 ± 25.7

3.4 ± 1.4

12.5 ± 10.2

85.1 ± 36.0

168.4 ± 27.3

55.8 ± 10.6

86.4 ± 21.1

21.1 ± 7

15.7 ± 4.9

13 ± 3.1

0.8 ± 0.1

Posttreatment; ()

5.4 ± 0.3

90 ± 6.2

115.1 ± 31.3

4.9 ± 7.7

23.5 ± 16.4

71.6 ± 24.5

161.1 ± 20.9

53.3 ± 7

86.4 ± 19.5

17 ± 2

13.6 ± 3.6

13.4 ± 2.8

0.8 ± 0.1

value^b

0.86

0.35

0.82

0.62

0.16

0.43

0.58

0.61

1

0.16

0.36

0.8

0.83

Data from seven healthy volunteers are presented as mean ± SD (standard deviation). The number () of volunteers is indicated.
^bStudent’s -test is used to compare the parameters before and after the volunteers took the B. pilosa formulation at a daily dose of 400 mg per person, ter in die. No statistical significance is found.